VT
EVH icon

Vise Technologies’s Evolent Health EVH Stock Holding History

Vise Technologies’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.8K Buy
17,119
+4,720
+38% +$18.1K ﹤0.01% 1745
2026
Q1 		$49.6K Hold
12,399
– – ﹤0.01% 1439
2025
Q4 		$49.6K Buy
+12,399
New +$68.9K ﹤0.01% 1452

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vise Technologies's EVH Position: Q2 2026 in Review

Vise Technologies increased its Evolent Health (EVH) stake by 38% in Q2 2026, buying an estimated $18.1K and bringing the position to 17,119 shares worth $92.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1745.

Vise Technologies first reported a position in EVH in Q4 2025 and has held it in 3 quarters since. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Vise Technologies held 17,119 shares of Evolent Health worth $92.8K as of Q2 2026.
  • Vise Technologies bought 4,720 Evolent Health shares in Q2 2026, an estimated $18.1K.
  • Evolent Health made up ﹤0.01% of Vise Technologies's portfolio in Q2 2026, its #1745 holding.
  • Vise Technologies first reported a position in Evolent Health in Q4 2025 and has held it in 3 quarters since.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.